Everolimus on CKD Progression in ADPKD Patients

Status Terminated

Clinical Trial Summary

The study will evaluate whether the administration of everolimus (1.5 mg/day) can slow down the progression of CKD in ADPKD patients.

Clinical Trial Description

Considering the inhibitor activity of Everolimus on mTOR, our hypothesis is to evaluate its possible utility on the progression of CKD in ADPKD patients by reducing the rate of increase of renal cysts. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01009957
Study type	Interventional
Source	A. Manzoni Hospital
Contact
Status	Terminated
Phase	Phase 2/Phase 3
Start date	June 2008
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04039061` - ADPKD Patient Registry
Enrolling by invitation	`NCT05215964` - The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
Recruiting	`NCT01680250` - Sirolimus for Massive Polycystic Liver	Phase 2/Phase 3
Completed	`NCT00286156` - Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Phase 1/Phase 2
Not yet recruiting	`NCT06036992` - Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
Completed	`NCT01931644` - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed	`NCT02739750` - Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Completed	`NCT03889392` - Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD
Completed	`NCT03948113` - Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
Recruiting	`NCT03726463` - Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD
Completed	`NCT03423810` - Assessing a Dose‐Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients	Early Phase 1